标题
The known unknowns of HPV natural history
作者
关键词
-
出版物
JOURNAL OF CLINICAL INVESTIGATION
Volume 121, Issue 12, Pages 4593-4599
出版商
American Society for Clinical Investigation
发表日期
2011-12-03
DOI
10.1172/jci57149
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in the United States
- (2013) Jane J. Kim ANNALS OF INTERNAL MEDICINE
- Human Papillomavirus (HPV) 6, 11, 16, and 18 Seroprevalence Is Associated with Sexual Practice and Age: Results from the Multinational HPV Infection in Men Study (HIM Study)
- (2011) B. Lu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Long term protection against cervical infection with the human papillomavirus: Review of currently available vaccines
- (2011) Barbara Romanowski Human vaccines & immunotherapeutics
- Genital Shedding of Herpes Simplex Virus Among Symptomatic and Asymptomatic Persons With HSV-2 Infection
- (2011) Elizabeth Tronstein JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Increases in Human Papillomavirus Detection During Early HIV Infection Among Women in Zimbabwe
- (2011) R. G. Nowak et al. JOURNAL OF INFECTIOUS DISEASES
- Rapid Rise in Detection of Human Papillomavirus (HPV) Infection Soon After Incident HIV Infection Among South African Women
- (2011) C. Wang et al. JOURNAL OF INFECTIOUS DISEASES
- Human Papillomavirus Testing in the Prevention of Cervical Cancer
- (2011) Mark Schiffman et al. JNCI-Journal of the National Cancer Institute
- Resident Memory T Cells (TRM) Are Abundant in Human Lung: Diversity, Function, and Antigen Specificity
- (2011) Rahul Purwar et al. PLoS One
- Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States
- (2011) Linda Ahdieh Grant et al. VACCINE
- Persistence of viral DNA in the epithelial basal layer suggests a model for papillomavirus latency following immune regression
- (2011) Gareth Adam Maglennon et al. VIROLOGY
- The natural history of human papillomavirus infections of the mucosal epithelia
- (2010) LOUISE T. CHOW et al. APMIS
- A review of prophylactic human papillomavirus vaccines: Recommendations and monitoring in the US
- (2010) Eileen F. Dunne et al. CANCER
- Incidence, Duration, and Reappearance of Type-Specific Cervical Human Papillomavirus Infections in Young Women
- (2010) R. P. Insinga et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Behavioral/Lifestyle and Immunologic Factors Associated with HPV Infection among Women Older Than 45 Years
- (2010) P. Gonzalez et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Human Papillomavirus Infection and Reinfection in Adult Women: the Role of Sexual Activity and Natural Immunity
- (2010) H. Trottier et al. CANCER RESEARCH
- Human Papillomavirus Vaccines
- (2010) Suzanne M. Garland et al. DRUGS
- Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years
- (2010) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Sexual Behaviors, Condom Use, and Sexual Health of Americans Over 50: Implications for Sexual Health Promotion for Older Adults
- (2010) Vanessa Schick et al. Journal of Sexual Medicine
- Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection
- (2010) A. C. Rodriguez et al. JNCI-Journal of the National Cancer Institute
- Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence
- (2010) S. K. Kjaer et al. JNCI-Journal of the National Cancer Institute
- Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections
- (2010) M. Safaeian et al. JNCI-Journal of the National Cancer Institute
- Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
- (2010) Nubia Muñoz et al. JNCI-Journal of the National Cancer Institute
- Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
- (2010) Guglielmo Ronco et al. LANCET ONCOLOGY
- High-Risk Human Papillomavirus Reactivation in Human Immunodeficiency Virus–Infected Women
- (2010) Regan N. Theiler et al. OBSTETRICS AND GYNECOLOGY
- Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes
- (2010) J. T. Schiffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis
- (2010) Nicolas Van de Velde et al. VACCINE
- Clinical update of the AS04-Adjuvanted human Papillomavirus-16/18 cervical cancer vaccine, cervarix®
- (2009) Tino F. Schwarz ADVANCES IN THERAPY
- A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
- (2009) S. K. Kjaer et al. Cancer Prevention Research
- Cigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: A longitudinal study
- (2009) Stuart Collins et al. EUROPEAN JOURNAL OF CANCER
- HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives
- (2009) Xavier Castellsagué et al. GYNECOLOGIC ONCOLOGY
- Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized Setting
- (2009) Maarit Leinonen et al. JNCI-Journal of the National Cancer Institute
- Efficacy of HPV DNA Testing With Cytology Triage and/or Repeat HPV DNA Testing in Primary Cervical Cancer Screening
- (2009) P. Naucler et al. JNCI-Journal of the National Cancer Institute
- Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial
- (2009) Nubia Muñoz et al. LANCET
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- Risk estimation for the next generation of prevention programmes for cervical cancer
- (2009) Hormuzd A Katki et al. LANCET ONCOLOGY
- HPV Screening for Cervical Cancer in Rural India
- (2009) Rengaswamy Sankaranarayanan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Use of Human Papillomavirus Seroepidemiology to Inform Vaccine Policy
- (2009) Mark Schiffman et al. SEXUALLY TRANSMITTED DISEASES
- Prevalence and Incidence of HPV Genital Infection in Women
- (2009) Christine Velicer et al. SEXUALLY TRANSMITTED DISEASES
- Persistent Antibodies to HPV Virus-Like Particles Following Natural Infection Are Protective Against Subsequent Cervicovaginal Infection with Related and Unrelated HPV
- (2009) Zainab A. Malik et al. VIRAL IMMUNOLOGY
- Risk of Female Human Papillomavirus Acquisition Associated with First Male Sex Partner
- (2008) Rachel L. Winer et al. JOURNAL OF INFECTIOUS DISEASES
- Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study
- (2008) Margaret RE McCredie et al. LANCET ONCOLOGY
- Modeling Cervical Cancer Prevention in Developed Countries
- (2008) Jane J. Kim et al. VACCINE
- Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia
- (2008) F. Xavier Bosch et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started